Home

cimasa picco tè atlantis clinical trial Attore Composizione Novità

ATLANTIS: Apixaban Has No Benefit Over Standard of Care Post-TAVI |  tctmd.com
ATLANTIS: Apixaban Has No Benefit Over Standard of Care Post-TAVI | tctmd.com

Atlantis Clinical | LinkedIn
Atlantis Clinical | LinkedIn

C. Michael Gibson MD on Twitter: "Dr. Jean-Philippe Collet presents the  results of the ATLANTIS trial: Net clinical benefit of Apixaban after TAVI  is not superior to SOC antithrombotic treatment. Full slide
C. Michael Gibson MD on Twitter: "Dr. Jean-Philippe Collet presents the results of the ATLANTIS trial: Net clinical benefit of Apixaban after TAVI is not superior to SOC antithrombotic treatment. Full slide

Is Lupin Atlantis Holdings S.A. late reporting EU clinical trials?
Is Lupin Atlantis Holdings S.A. late reporting EU clinical trials?

Anticoagulation Therapy in Patients Post-TAVR (Transcript)
Anticoagulation Therapy in Patients Post-TAVR (Transcript)

Andrew M. Goldsweig, MD, MS on Twitter: "LAAOS III, PARADISE-MI, ATLANTIS,  TRISCEND...and more! Late-breaking clinical trials are coming at #ACC21!  See you tomorrow at https://t.co/IYN26oyRKP! https://t.co/l8DVyMXarB" /  Twitter
Andrew M. Goldsweig, MD, MS on Twitter: "LAAOS III, PARADISE-MI, ATLANTIS, TRISCEND...and more! Late-breaking clinical trials are coming at #ACC21! See you tomorrow at https://t.co/IYN26oyRKP! https://t.co/l8DVyMXarB" / Twitter

Oral anti‐Xa anticoagulation after trans‐aortic valve implantation for  aortic stenosis: The randomized ATLANTIS trial | Semantic Scholar
Oral anti‐Xa anticoagulation after trans‐aortic valve implantation for aortic stenosis: The randomized ATLANTIS trial | Semantic Scholar

ATLANTIS: a randomised multi-arm phase II biomarker-directed umbrella  screening trial of maintenance targeted therapy after chemotherapy in  patients with advanced or metastatic urothelial cancer | Trials | Full Text
ATLANTIS: a randomised multi-arm phase II biomarker-directed umbrella screening trial of maintenance targeted therapy after chemotherapy in patients with advanced or metastatic urothelial cancer | Trials | Full Text

CPFT joins pioneering trial for schizophrenia treatment | Cambridge Network
CPFT joins pioneering trial for schizophrenia treatment | Cambridge Network

Cover Story | Big Data ADAPTABLE Trial Reveals a New Future For Clinical  Trials - American College of Cardiology
Cover Story | Big Data ADAPTABLE Trial Reveals a New Future For Clinical Trials - American College of Cardiology

The ATLANTIS Randomized Trial: Apixaban Versus Standard of Care After TAVI  - Cardiac Interventions Today
The ATLANTIS Randomized Trial: Apixaban Versus Standard of Care After TAVI - Cardiac Interventions Today

The ATLANTIS Randomized Trial: Apixaban Versus Standard of Care After TAVI  - Cardiac Interventions Today
The ATLANTIS Randomized Trial: Apixaban Versus Standard of Care After TAVI - Cardiac Interventions Today

Top Interventional Trials presented at ACC.21
Top Interventional Trials presented at ACC.21

Optimal Antithrombotic Strategy After Transcatheter Aortic Valve  Replacement: Is the “Less Is More” Concept Always Better? | Journal of the  American Heart Association
Optimal Antithrombotic Strategy After Transcatheter Aortic Valve Replacement: Is the “Less Is More” Concept Always Better? | Journal of the American Heart Association

ATLANTIS: a Phase III study of lurbinectedin/doxorubicin versus topotecan  or cyclophosphamide/doxorubicin/vincristine in patients with small-cell  lung cancer who have failed one prior platinum-containing line | Future  Oncology
ATLANTIS: a Phase III study of lurbinectedin/doxorubicin versus topotecan or cyclophosphamide/doxorubicin/vincristine in patients with small-cell lung cancer who have failed one prior platinum-containing line | Future Oncology

Atlantis Clinical | LinkedIn
Atlantis Clinical | LinkedIn

ATLANTIS - Capsule Summary Slidesets - WCLC Highlights - WCLC 2021 -  Oncology - Clinical Care Options
ATLANTIS - Capsule Summary Slidesets - WCLC Highlights - WCLC 2021 - Oncology - Clinical Care Options

The role of small airway dysfunction in asthma control and exacerbations: a  longitudinal, observational analysis using data from the ATLANTIS study -  The Lancet Respiratory Medicine
The role of small airway dysfunction in asthma control and exacerbations: a longitudinal, observational analysis using data from the ATLANTIS study - The Lancet Respiratory Medicine

Study design for patients in ATLANTIS trial. Abbreviations: MET MET... |  Download Scientific Diagram
Study design for patients in ATLANTIS trial. Abbreviations: MET MET... | Download Scientific Diagram

The ATLANTIS Randomized Trial: Apixaban Versus Standard of Care After TAVI  - Cardiac Interventions Today
The ATLANTIS Randomized Trial: Apixaban Versus Standard of Care After TAVI - Cardiac Interventions Today

ATLANTIS Trial | Stroke
ATLANTIS Trial | Stroke

Volunteers wanted to participate in antibody clinical trial
Volunteers wanted to participate in antibody clinical trial

ATLANTIS • CTRU Leeds Research Portal
ATLANTIS • CTRU Leeds Research Portal

Top Interventional Trials presented at ACC.21
Top Interventional Trials presented at ACC.21

ASCO GU 2022: A Randomized, Double Blind, Biomarker Selected, Phase II Clinical  Trial of Maintenance PARP Inhibition Following Chemotherapy for Metastatic  Urothelial Carcinoma: Final Analysis of the ATLANTIS Rucaparib Arm
ASCO GU 2022: A Randomized, Double Blind, Biomarker Selected, Phase II Clinical Trial of Maintenance PARP Inhibition Following Chemotherapy for Metastatic Urothelial Carcinoma: Final Analysis of the ATLANTIS Rucaparib Arm

Atlantia Clinical Trials | Food contract research organisation (CRO)
Atlantia Clinical Trials | Food contract research organisation (CRO)

The randomized, controlled ATLANTIS trial of aquatic therapy for chronic  venous insufficiency - ScienceDirect
The randomized, controlled ATLANTIS trial of aquatic therapy for chronic venous insufficiency - ScienceDirect

Despite Failure to Meet Phase III Primary Endpoint, Jazz's SCLC Drug Holds  Promise | BioSpace
Despite Failure to Meet Phase III Primary Endpoint, Jazz's SCLC Drug Holds Promise | BioSpace